LT3405197T - Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui - Google Patents

Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui

Info

Publication number
LT3405197T
LT3405197T LTEPPCT/EP2017/051133T LTEP2017051133T LT3405197T LT 3405197 T LT3405197 T LT 3405197T LT EP2017051133 T LTEP2017051133 T LT EP2017051133T LT 3405197 T LT3405197 T LT 3405197T
Authority
LT
Lithuania
Prior art keywords
delgocitinib
treatment
hand eczema
chronic hand
chronic
Prior art date
Application number
LTEPPCT/EP2017/051133T
Other languages
English (en)
Inventor
Tero WENNBERG
Anders Per SØRENSEN
Original Assignee
Leo Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma A/S filed Critical Leo Pharma A/S
Publication of LT3405197T publication Critical patent/LT3405197T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
LTEPPCT/EP2017/051133T 2016-01-21 2017-01-20 Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui LT3405197T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16152215 2016-01-21
PCT/EP2017/051133 WO2017125523A1 (en) 2016-01-21 2017-01-20 Treatment of hand eczema

Publications (1)

Publication Number Publication Date
LT3405197T true LT3405197T (lt) 2023-11-27

Family

ID=55236207

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2017/051133T LT3405197T (lt) 2016-01-21 2017-01-20 Delgocitinibo panaudojimas lėtinės rankų egzemos gydymui

Country Status (25)

Country Link
US (2) US20200397787A1 (lt)
EP (2) EP4257205A3 (lt)
JP (1) JP6929860B2 (lt)
KR (1) KR20180102662A (lt)
CN (3) CN117159554A (lt)
AU (2) AU2017209932A1 (lt)
BR (1) BR112018014769A2 (lt)
CA (1) CA3010547A1 (lt)
DK (1) DK3405197T3 (lt)
ES (1) ES2963784T3 (lt)
FI (1) FI3405197T3 (lt)
HR (1) HRP20231448T1 (lt)
HU (1) HUE064192T2 (lt)
IL (2) IL297379A (lt)
LT (1) LT3405197T (lt)
MX (2) MX2018008449A (lt)
PL (1) PL3405197T3 (lt)
PT (1) PT3405197T (lt)
RS (1) RS64798B1 (lt)
RU (1) RU2018130097A (lt)
SG (2) SG11201805394QA (lt)
SI (1) SI3405197T1 (lt)
TW (1) TWI783921B (lt)
UA (1) UA123780C2 (lt)
WO (1) WO2017125523A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3968997A1 (en) * 2019-05-15 2022-03-23 Leo Pharma A/S Treatment of cutaneous lupus erythematosus
WO2022167913A1 (en) * 2021-02-02 2022-08-11 Pfizer Inc. Dosing regime for treatment of chronic hand eczema

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US20130302298A1 (en) * 2010-11-30 2013-11-14 Bio-K Plus International Inc. Treatment and prevention of eczema
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent

Also Published As

Publication number Publication date
JP2019502734A (ja) 2019-01-31
TW201736382A (zh) 2017-10-16
RS64798B1 (sr) 2023-11-30
CN117159553A (zh) 2023-12-05
FI3405197T3 (fi) 2023-11-23
TWI783921B (zh) 2022-11-21
PT3405197T (pt) 2023-12-06
RU2018130097A3 (lt) 2020-05-25
IL260094A (en) 2018-07-31
HRP20231448T1 (hr) 2024-03-01
EP4257205A2 (en) 2023-10-11
EP4257205A3 (en) 2023-12-20
PL3405197T3 (pl) 2024-02-12
KR20180102662A (ko) 2018-09-17
SG10202006830WA (en) 2020-08-28
JP6929860B2 (ja) 2021-09-01
CA3010547A1 (en) 2017-07-27
SI3405197T1 (sl) 2024-03-29
US20230138114A1 (en) 2023-05-04
EP3405197A1 (en) 2018-11-28
WO2017125523A1 (en) 2017-07-27
CN117159554A (zh) 2023-12-05
ES2963784T3 (es) 2024-04-02
CN108472297A (zh) 2018-08-31
IL297379A (en) 2022-12-01
BR112018014769A2 (pt) 2018-12-11
HUE064192T2 (hu) 2024-02-28
AU2022252766A1 (en) 2022-11-03
MX2022005915A (es) 2022-06-27
RU2018130097A (ru) 2020-02-21
MX2018008449A (es) 2018-08-09
DK3405197T3 (da) 2023-11-27
UA123780C2 (uk) 2021-06-02
AU2017209932A1 (en) 2018-07-05
TW202332451A (zh) 2023-08-16
SG11201805394QA (en) 2018-08-30
US20200397787A1 (en) 2020-12-24
EP3405197B1 (en) 2023-09-06

Similar Documents

Publication Publication Date Title
HK1247202A1 (zh) 用於治療癌症的化合物
IL259996A (en) Combinations for cancer treatment
SI3122358T1 (sl) Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka
IL311081A (en) Use of pyridofidine to treat functional decline
SI3261726T1 (sl) Sestavek za zdravljenje aken
HK1258276A1 (zh) 用於治療hiv的化合物和組合
IL248767B (en) Trimethoxyphenyl-benzaimidazole compounds for cancer treatment
PT3377064T (pt) Orvepitante para o tratamento da tosse crónica
PL3122349T3 (pl) Kompozycje do leczenia samotrawienia
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
EP3440052C0 (en) COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
IL260094A (en) Treatment of hand eczema
IL252493B (en) Compounds for use in the prevention or treatment of cancer
EP3145525A4 (en) Use of microperoxidases for the treatment of carboxyhemoglobinemia
IL255167A0 (en) Compounds for the treatment of cancer
PL3303486T3 (pl) Kompozycja do obróbki powierzchni
ZA201704589B (en) Compounds for the treatment of cancer
PT3524255T (pt) Composição para o tratamento do acne
GB201511503D0 (en) Finishing treatment